A new report suggests corticosteroids likely are not a panacea for ocular surface disease, a potential adverse effect of trabeculectomy. Patients who took steroid eye drops before trabeculectomy for ...
Please provide your email address to receive an email when new articles are posted on . CBT-004 demonstrated rapid onset of improvement in conjunctival hyperemia. Cloudbreak Pharma is advancing ...
Please provide your email address to receive an email when new articles are posted on . “Conjunctival redness or hyperemia is one of the most common ocular responses to insults of various origin and ...
Novel preservative-free CBT-004 eye drop formulation demonstrates statistically significant improvements in conjunctival hyperemia and patient-reported symptoms with excellent safety profile IRVINE, ...
Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.
CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic ...
Salt Lake City, Utah--(Newsfile Corp. - December 14, 2021) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced topline data from its vehicle-controlled, randomized ...
This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results